Can rare lymphocytes combat rheumatoid arthritis?

Immunologists have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis. ILCs have several functional similarities to T-cells and are important agents of our congenital immune system. The researchers’ findings could form the basis for new approaches for treating rheumatoid arthritis.

Leave a Reply

Your email address will not be published. Required fields are marked *